Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia (NCT07783373)

🧪 Interventions in This Study

• xanomeline-trospium chloride (DRUG)
• Oral antipsychotics (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Local Institution - 0001 — Suwanee, Georgia

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Schizophrenia

• Young Adults With Violent Behavior During Early Psychosis (Aim 2) — New York, New York
• Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia — Toronto, Ontario
• Ketogenic Diet in People With Schizophrenia — Catonsville, Maryland
• Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia — Toronto, Ontario
• Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography — Toronto, Ontario

Explore by condition: All Schizophrenia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.